High dose idarubicine, busulphan and melphalan conditioning regimen for lymphoproliferative disorders

被引：0
|
作者：
Trasarti, S [1 ]
Meloni, G [1 ]
Capria, S [1 ]
Bongarzoni, V [1 ]
Ferrazza, G [1 ]
Iodice, F [1 ]
Proia, A [1 ]
Trisolini, SM [1 ]
Mandelli, F [1 ]
机构：
[1] Univ Rome La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Roma, Italy
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
352
引用
收藏
页码：S100 / S100
页数：1
相关论文
共 50 条
  • [31] CONTINUOUS INFUSION HIGH DOSE IDARUBICIN AND INTRAVENOUS BUSULPHAN AS CONDITIONING REGIMEN TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Ferrara, F.
    Palmieri, S.
    Copia, C.
    Criscuolo, C.
    Izzo, T.
    Pedata, M.
    Pollio, F.
    Viola, A.
    Falco, C.
    Mele, G.
    HAEMATOLOGICA, 2008, 93 : S133 - S133
  • [32] High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma
    Atra, A
    Whelan, JS
    Calvagna, V
    Shankar, AG
    Ashley, S
    Shepherd, V
    Souhami, RL
    Pinkerton, CR
    BONE MARROW TRANSPLANTATION, 1997, 20 (10) : 843 - 846
  • [33] High-dose busulphan/melphalan with autologous stem cell rescue in Ewing’s sarcoma
    A Atra
    JS Whelan
    V Calvagna
    AG Shankar
    S Ashley
    V Shepherd
    RL Souhami
    CR Pinkerton
    Bone Marrow Transplantation, 1997, 20 : 843 - 846
  • [34] The effectiveness of the conditioning regimen high dose melphalan with bortezomib with autologous transplantation of hematopoietic stem cells in patients with multiple myeloma
    Khorobrykh, Marina
    Zorina, Natalia
    Minaeva, Natalia
    Sherstnev, Philipp
    Paramonov, Igor
    BONE MARROW TRANSPLANTATION, 2018, 53 : 293 - 294
  • [35] Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study
    Roussel, Murielle
    Lauwers-Cances, Valerie
    Macro, Margaret
    Leleu, Xavier
    Royer, Bruno
    Hulin, Cyrille
    Karlin, Lionel
    Perrot, Aurore
    Touzeau, Cyrille
    Chretien, Marie-Lorraine
    Rigaudeau, Sophie
    Dib, Mamoun
    Nicolas-Virelizier, Emmanuelle
    Escoffre-Barbe, Martine
    Belhadj, Karim
    Mariette, Clara
    Stoppa, Anne-Marie
    Araujo, Carla
    Doyen, Chantal
    Fontan, Jean
    Kolb, Brigitte
    Garderet, Laurent
    Brechignac, Sabine
    Malfuson, Jean-Valere
    Jaccard, Arnaud
    Lenain, Pascal
    Borel, Cecile
    Hebraud, Benjamin
    Benbrahim, Omar
    Dorvaux, Veronique
    Manier, Salomon
    Augeul-Meunier, Karine
    Vekemans, Marie-Christiane
    Randriamalala, Edouard
    Chaoui, Driss
    Caers, Jo
    Chaleteix, Carine
    Benboubker, Lofti
    Vincent, Laure
    Glaisner, Sylvie
    Zunic, Patricia
    Slama, Borhane
    Eveillard, Jean-Richard
    Humbrecht-Kraut, Catherine
    Morel, Veronique
    Mineur, Philippe
    Eisenmann, Jean-Claude
    Demarquette, Helene
    Richez, Valentine
    Vignon, Marguerite
    BLOOD, 2022, 139 (18) : 2747 - 2757
  • [36] A preparatory regimen of high-dose busulphan and melphalan for autologous haematopoietic cell transplantation in childhood high-risk acute myeloblastic leukaemia, neuroblastoma and Ewing sarcoma
    Gorczynska, E
    Turkiewicz, D
    Toporski, J
    Kalwak, K
    Dyla, A
    Chybicka, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S223 - S223
  • [37] Busulphan and melphalan conditioning for autologous BM/PBSC transplantation in multiple myeloma.
    Clark, A
    Mitchell, L
    Alcorn, M
    Tansey, P
    Cook, G
    Franklin, IM
    BONE MARROW TRANSPLANTATION, 1998, 21 : S99 - S99
  • [38] Fludarabine, Melphalan, and Alemtuzumab Conditioning Regimen in High Risk Leukemia: The Arkansas Experience
    Ravilla, Rahul
    Atwal, Dinesh
    Appalanaidu, Sasapu
    Motwani, Pooja
    Emanuel, Peter
    Jethava, Yogesh
    Veeraputhiran, Muthu
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S295 - S296
  • [39] HIGH DOSE IDARUBICIN AS CONTINUOUS INFUSION AND INTRAVENOUS BUSULPHAN AS CONDITIONING REGIMEN TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
    Ferrara, F.
    Palmieri, S.
    Copia, C.
    Criscuolo, C.
    Pedata, M.
    Izzo, T.
    Pollio, E.
    Viola, A.
    Mele, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 566 - 566
  • [40] Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)
    Jung, Sung-Hoon
    Lee, Je-Jung
    Kim, Mihee
    Min, Chang-Ki
    Lee, Ji Yun
    Jo, Jae-Cheol
    Yoon, Sung-Soo
    Lim, Sung-Nam
    Do, Young Rok
    Kim, Kihyun
    Lee, Jae Hoon
    Yoo, Kwai Han
    Bae, Sung Hwa
    Yi, Jun Ho
    Jung, Jongheon
    Eom, Hyeon-Seok
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S115 - S115
12345